Cytogenetic and Molecular Genetic Studies in Bone Sarcomas

Completed

Conditions studied: Lung Cancer

In brief

To establish a serial ascertainement of specimens from patients with bone sarcomas to be used in ongoing cytogenetic and molecular genetic analyses. These data will be integrated and correlated with the established Orthopaedic Service clinical database.

Key facts

Study ID

NCT00579930

Run by

Memorial Sloan Kettering Cancer Center

People needed

1

Starts

1993-12-01

Expected to finish

2016-02-01

Last updated by the study team

2016-02-25

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients must be undergoing diagnostic biopsy or resection of their primary or metastatic bone sarcoma for therapeutic purposes.
• The specimen must be large enough to allow routine pathological analysis, with the specimen for research excised from residual tissue that would otherwise be discarded.

You may not qualify if…

• N/A

Where it is running

• Memorial Sloan Kettering Cancer Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.